Skip to main content

Table 1 Demographic characteristics of the patients with hepatitis C in Taiwan in 2000-2011

From: Utilization and prescription patterns of traditional Chinese medicine for patients with hepatitis C in Taiwan: a population-based study

Variable Non-TCM TCM p value
N = 2876 (33.57 %) N = 5691 (66.43 %)
n % n %
Sex      <0.0001
 Female 1148 39.92 3081 54.14  
 Male 1728 60.08 2610 45.86  
Age at baseline      <0.0001
 18−39 364 12.66 945 16.61  
 40−64 1451 50.45 3395 59.66  
  ≥ 65 1061 36.89 1351 23.74  
 Mean (STD) 58.34 14.85 53.92 13.97  
Urbanizationa      <0.0001
 1 (highest) 574 19.96 1215 21.35  
 2 731 25.42 1652 29.03  
 3 447 15.54 939 16.50  
 4+ (lowest) 1124 39.08 1885 33.12  
Co-morbidity
 Hepatitis B 570 19.82 1356 23.83 <0.0001
 Liver cirrhosis 989 34.39 1618 28.43 <0.0001
 hepatocellular carcinoma 535 18.60 898 15.78 0.0009
 Alcohol-related disease 294 10.22 477 8.38 0.0049
 Chronic obstructive pulmonary disease 508 17.66 1402 24.64 <0.0001
 Diabetes Mellitus 1046 36.37 2143 37.66 0.2449
 Thyroid disorders 145 5.04 631 11.09 <0.0001
 Rheumatoid arthritis 89 3.09 400 7.03 <0.0001
 Osteoarthritis 953 33.14 2922 51.34 <0.0001
 Depression 174 6.05 650 11.42 <0.0001
 Sicca syndrome 78 2.71 423 7.43 <0.0001
Charlson comorbidity index score    <0.0001
 0 1203 41.83 3024 53.14  
 1 377 13.11 769 13.51  
 More than 2 1296 45.06 1898 33.35  
Anti-viral or hepatoprotective agents
 Interferon alfa 392 13.63 974 17.11 <0.0001
 Ribavirin 391 13.60 973 17.10 <0.0001
 Silymarin 1916 66.62 4204 73.87 <0.0001
Times of visits (mean, SD) 15.61 17.18 21.23 23.18 <0.0001
  1. aThe townships within which subjects registered for insurance were grouped into 4 levels of urbanization, based on a score calculated by incorporating variables indicating population density (people/km2), and population ratio of different educational levels, population ratio of elderly, population ratio of people of agriculture workers and the number of physicians per 100,000 people